Skip to content
Find Clinical Trials
Find Clinical Trials
Home » Find Clinical Trials » Impact of Daflon 500 mg on the progression of chronic venous disease and symptoms in patients operated on for varicose veins with conservation of the great saphenous vein. A multicentre, double blind randomised, placebo controlled, parallel group study. –

Impact of Daflon 500 mg on the progression of chronic venous disease and symptoms in patients operated on for varicose veins with conservation of the great saphenous vein. A multicentre, double blind randomised, placebo controlled, parallel group study. –

Share Print
Servier Protocol Code: CL2-05682-102 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2010-021270-11

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00
Results
English (USA)
Interventions / Treatments
  • venous disease
  • MICRONISED PURIFIED FLAVONOID FRACTION
  • S005682
Other study id numbers
  • CL2-05682-102